CEBP Infection and Cancer: Biology, Therapeutics, and Prevention Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lamar, C. A.
Right arrow Articles by Stephenson, H. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lamar, C. A.
Right arrow Articles by Stephenson, H. E., Jr.
Cancer Epidemiology Biomarkers & Prevention Vol. 12, 380-383, April 2003
© 2003 American Association for Cancer Research


Short Communication

Serum Sex Hormones and Breast Cancer Risk Factors in Postmenopausal Women1

Charisee A. Lamar2, Joanne F. Dorgan, Christopher Longcope, Frank Z. Stanczyk, Roni T. Falk and Hugh E. Stephenson, Jr.

Extramural Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH [C. A. L.] and Division of Cancer Epidemiology and Genetics, National Cancer Institute [R. T. F.], Bethesda, Maryland 20892; Population Science Division, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 [J. F. D.]; Departments of Obstetrics and Gynecology and Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01655 [C. L.]; Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles, California 90033 [F. Z. S.]; and Department of Surgery, University of Missouri Health Sciences Center, Columbia, Missouri 65212 [H. E. S.]

Postmenopausal women with elevated serum estrogens and androgens are at an increased risk of breast cancer. We evaluated associations of serum estrogen and androgen levels with age, anthropometry, and reproductive history to assess whether these characteristics could potentially modify breast cancer risk through hormonal mechanisms. A cross-sectional study was conducted among 133 postmenopausal women who donated blood to the serum bank (Columbia, MO) and served as controls in a previous prospective nested case control study of serum hormones and breast cancer risk. Standard regression methods were used to calculate adjusted means and test for trends in relationships of serum hormone concentrations with breast cancer risk factors. All analyses were performed on the loge scale, and all models included assay batch, date, and time of blood collection. Serum levels of estradiol, non-sex hormone binding globulin bound estradiol, estrone, estrone sulfate, and testosterone increased significantly with increasing body mass index (BMI), whereas sex hormone binding globulin levels decreased. After adjusting for BMI, nulliparous women tended to have higher testosterone levels compared with parous women (P = 0.05), but there was no evidence of a trend of decreasing testosterone with increasing parity. Dehydroepiandrosterone, its sulfate, and androstenediol decreased significantly with increasing age. Although BMI and parity could potentially modify breast cancer risk through hormonal mechanisms, age-related increases in breast cancer incidence do not appear to be mediated through changes in serum levels of the hormones evaluated.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. J. Cleveland, S. M. Eng, P. E. Abrahamson, J. A. Britton, S. L. Teitelbaum, A. I. Neugut, and M. D. Gammon
Weight Gain Prior to Diagnosis and Survival from Breast Cancer
Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1803 - 1811.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H. J. Baer, G. A. Colditz, W. C. Willett, and J. F. Dorgan
Adiposity and Sex Hormones in Girls
Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1880 - 1888.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. K. Whiteman, S. D. Hillis, K. M. Curtis, J. A. McDonald, P. A. Wingo, and P. A. Marchbanks
Body Mass and Mortality After Breast Cancer Diagnosis
Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 2009 - 2014.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. R. Davis, S. L. Davison, S. Donath, and R. J. Bell
Circulating Androgen Levels and Self-reported Sexual Function in Women
JAMA, July 6, 2005; 294(1): 91 - 96.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Chubak, S. S. Tworoger, Y. Yasui, C. M. Ulrich, F. Z. Stanczyk, and A. McTiernan
Associations between Reproductive and Menstrual Factors and Postmenopausal Sex Hormone Concentrations
Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1296 - 1301.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2003 by the American Association for Cancer Research.